nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Methotrexate—germ cell cancer	0.213	0.313	CbGbCtD
Furosemide—SLC22A5—Dactinomycin—germ cell cancer	0.121	0.177	CbGbCtD
Furosemide—SLC22A11—Methotrexate—germ cell cancer	0.0632	0.0927	CbGbCtD
Furosemide—ABCC2—Vinblastine—germ cell cancer	0.0588	0.0862	CbGbCtD
Furosemide—ABCC2—Cisplatin—germ cell cancer	0.0539	0.0791	CbGbCtD
Furosemide—ABCC2—Etoposide—germ cell cancer	0.053	0.0777	CbGbCtD
Furosemide—SLC22A8—Methotrexate—germ cell cancer	0.0368	0.0539	CbGbCtD
Furosemide—ABCC2—Methotrexate—germ cell cancer	0.035	0.0513	CbGbCtD
Furosemide—SLC22A6—Methotrexate—germ cell cancer	0.0256	0.0376	CbGbCtD
Furosemide—ALB—Methotrexate—germ cell cancer	0.0218	0.032	CbGbCtD
Furosemide—SLC22A8—choroid plexus—germ cell cancer	0.00933	0.0774	CbGeAlD
Furosemide—CA6—ear—germ cell cancer	0.00611	0.0506	CbGeAlD
Furosemide—SLC12A1—urine—germ cell cancer	0.0043	0.0357	CbGeAlD
Furosemide—SLC12A1—appendage—germ cell cancer	0.00419	0.0347	CbGeAlD
Furosemide—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.00397	0.0928	CbGpPWpGaD
Furosemide—SLC22A8—optic choroid—germ cell cancer	0.00358	0.0297	CbGeAlD
Furosemide—SLCO2A1—Transport of organic anions—AVP—germ cell cancer	0.00343	0.0802	CbGpPWpGaD
Furosemide—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00319	0.0746	CbGpPWpGaD
Furosemide—SLC12A1—ganglion—germ cell cancer	0.00293	0.0243	CbGeAlD
Furosemide—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00269	0.0629	CbGpPWpGaD
Furosemide—SLC22A8—urine—germ cell cancer	0.0025	0.0207	CbGeAlD
Furosemide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00243	0.0569	CbGpPWpGaD
Furosemide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00203	0.0475	CbGpPWpGaD
Furosemide—CA4—ganglion—germ cell cancer	0.00158	0.0131	CbGeAlD
Furosemide—SLCO2A1—neck—germ cell cancer	0.00154	0.0128	CbGeAlD
Furosemide—CA5A—endocrine gland—germ cell cancer	0.00143	0.0119	CbGeAlD
Furosemide—PGD—neck—germ cell cancer	0.00137	0.0114	CbGeAlD
Furosemide—SLCO2A1—trigeminal ganglion—germ cell cancer	0.00133	0.011	CbGeAlD
Furosemide—SLCO2A1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00127	0.0298	CbGpPWpGaD
Furosemide—CA14—telencephalon—germ cell cancer	0.00126	0.0104	CbGeAlD
Furosemide—PGD—trigeminal ganglion—germ cell cancer	0.00118	0.00982	CbGeAlD
Furosemide—SLCO2A1—eye—germ cell cancer	0.00115	0.00949	CbGeAlD
Furosemide—SLC12A1—telencephalon—germ cell cancer	0.00113	0.00938	CbGeAlD
Furosemide—CA7—midbrain—germ cell cancer	0.00109	0.009	CbGeAlD
Furosemide—CA12—eye—germ cell cancer	0.00108	0.00893	CbGeAlD
Furosemide—PGD—eye—germ cell cancer	0.00102	0.00846	CbGeAlD
Furosemide—PGD—retina—germ cell cancer	0.00101	0.00839	CbGeAlD
Furosemide—SLCO2A1—skin of body—germ cell cancer	0.000996	0.00826	CbGeAlD
Furosemide—CA14—medulla oblongata—germ cell cancer	0.00099	0.00821	CbGeAlD
Furosemide—SLCO2A1—decidua—germ cell cancer	0.00099	0.0082	CbGeAlD
Furosemide—CA12—telencephalon—germ cell cancer	0.000983	0.00815	CbGeAlD
Furosemide—PGD—telencephalon—germ cell cancer	0.000931	0.00771	CbGeAlD
Furosemide—CA14—adrenal gland—germ cell cancer	0.000916	0.0076	CbGeAlD
Furosemide—CA6—head—germ cell cancer	0.000912	0.00756	CbGeAlD
Furosemide—CA14—midbrain—germ cell cancer	0.000905	0.0075	CbGeAlD
Furosemide—CA4—neck—germ cell cancer	0.000897	0.00744	CbGeAlD
Furosemide—PGD—skin of body—germ cell cancer	0.000888	0.00736	CbGeAlD
Furosemide—CA14—spinal cord—germ cell cancer	0.000883	0.00732	CbGeAlD
Furosemide—PGD—decidua—germ cell cancer	0.000882	0.00731	CbGeAlD
Furosemide—SLCO2A1—uterus—germ cell cancer	0.000866	0.00718	CbGeAlD
Furosemide—PGD—NRF2 pathway—SLC2A3—germ cell cancer	0.00086	0.0201	CbGpPWpGaD
Furosemide—CA1—eye—germ cell cancer	0.000854	0.00708	CbGeAlD
Furosemide—SLCO2A1—pituitary gland—germ cell cancer	0.00085	0.00705	CbGeAlD
Furosemide—CA7—cerebellum—germ cell cancer	0.00084	0.00697	CbGeAlD
Furosemide—CA9—endocrine gland—germ cell cancer	0.000838	0.00695	CbGeAlD
Furosemide—SLC22A8—trigeminal ganglion—germ cell cancer	0.000836	0.00693	CbGeAlD
Furosemide—CA9—testis—germ cell cancer	0.000799	0.00662	CbGeAlD
Furosemide—SLC12A1—spinal cord—germ cell cancer	0.000793	0.00657	CbGeAlD
Furosemide—CA1—telencephalon—germ cell cancer	0.000778	0.00645	CbGeAlD
Furosemide—PGD—gonad—germ cell cancer	0.000777	0.00644	CbGeAlD
Furosemide—PGD—uterus—germ cell cancer	0.000772	0.0064	CbGeAlD
Furosemide—SLCO2A1—adrenal gland—germ cell cancer	0.000759	0.00629	CbGeAlD
Furosemide—PGD—pituitary gland—germ cell cancer	0.000758	0.00628	CbGeAlD
Furosemide—CA2—neck—germ cell cancer	0.000744	0.00617	CbGeAlD
Furosemide—CA9—cerebellum—germ cell cancer	0.000738	0.00612	CbGeAlD
Furosemide—CA5B—gonad—germ cell cancer	0.000736	0.0061	CbGeAlD
Furosemide—SLC22A11—endocrine gland—germ cell cancer	0.000734	0.00609	CbGeAlD
Furosemide—CA9—Cellular responses to stress—PHC1—germ cell cancer	0.000733	0.0171	CbGpPWpGaD
Furosemide—PGD—medulla oblongata—germ cell cancer	0.000731	0.00606	CbGeAlD
Furosemide—SLC22A8—eye—germ cell cancer	0.00072	0.00597	CbGeAlD
Furosemide—SLCO2A1—female gonad—germ cell cancer	0.000708	0.00587	CbGeAlD
Furosemide—SLC12A1—head—germ cell cancer	0.000704	0.00584	CbGeAlD
Furosemide—CA14—cerebellum—germ cell cancer	0.0007	0.0058	CbGeAlD
Furosemide—CA4—brainstem—germ cell cancer	0.000686	0.00568	CbGeAlD
Furosemide—CA7—brain—germ cell cancer	0.000683	0.00566	CbGeAlD
Furosemide—SLC12A1—testis—germ cell cancer	0.00068	0.00564	CbGeAlD
Furosemide—PGD—adrenal gland—germ cell cancer	0.000677	0.00561	CbGeAlD
Furosemide—PGD—midbrain—germ cell cancer	0.000668	0.00554	CbGeAlD
Furosemide—SLCO2A1—endocrine gland—germ cell cancer	0.000659	0.00546	CbGeAlD
Furosemide—PGD—bone marrow—germ cell cancer	0.000655	0.00543	CbGeAlD
Furosemide—PGD—spinal cord—germ cell cancer	0.000652	0.0054	CbGeAlD
Furosemide—SLCO2A1—head—germ cell cancer	0.00065	0.00539	CbGeAlD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000649	0.0152	CbGpPWpGaD
Furosemide—CA2—trigeminal ganglion—germ cell cancer	0.000642	0.00532	CbGeAlD
Furosemide—CA5B—adrenal gland—germ cell cancer	0.000641	0.00531	CbGeAlD
Furosemide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000639	0.015	CbGpPWpGaD
Furosemide—SLC22A5—trigeminal ganglion—germ cell cancer	0.000632	0.00524	CbGeAlD
Furosemide—PGD—female gonad—germ cell cancer	0.000631	0.00523	CbGeAlD
Furosemide—SLCO2A1—testis—germ cell cancer	0.000628	0.00521	CbGeAlD
Furosemide—CA2—embryo—germ cell cancer	0.00062	0.00514	CbGeAlD
Furosemide—CA12—endocrine gland—germ cell cancer	0.00062	0.00514	CbGeAlD
Furosemide—CA12—head—germ cell cancer	0.000612	0.00507	CbGeAlD
Furosemide—CA4—telencephalon—germ cell cancer	0.000608	0.00504	CbGeAlD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000592	0.0139	CbGpPWpGaD
Furosemide—PGD—endocrine gland—germ cell cancer	0.000587	0.00487	CbGeAlD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000583	0.0136	CbGpPWpGaD
Furosemide—PGD—head—germ cell cancer	0.000579	0.0048	CbGeAlD
Furosemide—CA14—brain—germ cell cancer	0.000569	0.00471	CbGeAlD
Furosemide—CA2—brainstem—germ cell cancer	0.000568	0.00471	CbGeAlD
Furosemide—ALB—Transport of organic anions—AVP—germ cell cancer	0.000565	0.0132	CbGpPWpGaD
Furosemide—PGD—testis—germ cell cancer	0.00056	0.00464	CbGeAlD
Furosemide—CA5B—endocrine gland—germ cell cancer	0.000556	0.00461	CbGeAlD
Furosemide—CA2—eye—germ cell cancer	0.000553	0.00459	CbGeAlD
Furosemide—CA5B—head—germ cell cancer	0.000549	0.00455	CbGeAlD
Furosemide—CA2—retina—germ cell cancer	0.000548	0.00455	CbGeAlD
Furosemide—CA1—bone marrow—germ cell cancer	0.000548	0.00454	CbGeAlD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000547	0.0128	CbGpPWpGaD
Furosemide—CA1—spinal cord—germ cell cancer	0.000545	0.00452	CbGeAlD
Furosemide—PGD—Carbohydrate metabolism—SLC2A3—germ cell cancer	0.000543	0.0127	CbGpPWpGaD
Furosemide—SLC22A5—retina—germ cell cancer	0.00054	0.00447	CbGeAlD
Furosemide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000539	0.0126	CbGpPWpGaD
Furosemide—CA5B—testis—germ cell cancer	0.00053	0.0044	CbGeAlD
Furosemide—PGD—cerebellum—germ cell cancer	0.000517	0.00429	CbGeAlD
Furosemide—SLC12A1—brain—germ cell cancer	0.00051	0.00423	CbGeAlD
Furosemide—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000509	0.00329	CcSEcCtD
Furosemide—Urethral disorder—Ifosfamide—germ cell cancer	0.000505	0.00327	CcSEcCtD
Furosemide—CA2—telencephalon—germ cell cancer	0.000505	0.00418	CbGeAlD
Furosemide—ALB—adrenal gland—germ cell cancer	0.000497	0.00412	CbGeAlD
Furosemide—Vasculitis—Methotrexate—germ cell cancer	0.000497	0.00322	CcSEcCtD
Furosemide—Thrombocytopenia—Vinblastine—germ cell cancer	0.000496	0.00321	CcSEcCtD
Furosemide—Visual impairment—Ifosfamide—germ cell cancer	0.000496	0.00321	CcSEcCtD
Furosemide—CA4—pituitary gland—germ cell cancer	0.000495	0.00411	CbGeAlD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000495	0.0116	CbGpPWpGaD
Furosemide—SLC22A6—brain—germ cell cancer	0.000495	0.0041	CbGeAlD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000494	0.0116	CbGpPWpGaD
Furosemide—Blood uric acid increased—Methotrexate—germ cell cancer	0.000494	0.0032	CcSEcCtD
Furosemide—CA1—endocrine gland—germ cell cancer	0.000491	0.00407	CbGeAlD
Furosemide—Erythema—Dactinomycin—germ cell cancer	0.000489	0.00317	CcSEcCtD
Furosemide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000488	0.0114	CbGpPWpGaD
Furosemide—Erythema multiforme—Ifosfamide—germ cell cancer	0.000487	0.00315	CcSEcCtD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000487	0.0114	CbGpPWpGaD
Furosemide—Renal failure—Cisplatin—germ cell cancer	0.000486	0.00315	CcSEcCtD
Furosemide—Anaemia—Bleomycin—germ cell cancer	0.000485	0.00314	CcSEcCtD
Furosemide—CA1—head—germ cell cancer	0.000485	0.00402	CbGeAlD
Furosemide—Anorexia—Vinblastine—germ cell cancer	0.000483	0.00313	CcSEcCtD
Furosemide—CA2—skin of body—germ cell cancer	0.000481	0.00399	CbGeAlD
Furosemide—Eye disorder—Ifosfamide—germ cell cancer	0.000481	0.00312	CcSEcCtD
Furosemide—Tinnitus—Ifosfamide—germ cell cancer	0.00048	0.00311	CcSEcCtD
Furosemide—CA2—decidua—germ cell cancer	0.000478	0.00396	CbGeAlD
Furosemide—CA4—medulla oblongata—germ cell cancer	0.000478	0.00396	CbGeAlD
Furosemide—SLC22A5—skin of body—germ cell cancer	0.000474	0.00393	CbGeAlD
Furosemide—SLCO2A1—brain—germ cell cancer	0.000471	0.00391	CbGeAlD
Furosemide—Leukopenia—Bleomycin—germ cell cancer	0.00047	0.00304	CcSEcCtD
Furosemide—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000468	0.00303	CcSEcCtD
Furosemide—Angiopathy—Ifosfamide—germ cell cancer	0.000467	0.00303	CcSEcCtD
Furosemide—ABCC2—adrenal gland—germ cell cancer	0.000466	0.00386	CbGeAlD
Furosemide—Immune system disorder—Ifosfamide—germ cell cancer	0.000465	0.00301	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00046	0.0108	CbGpPWpGaD
Furosemide—Arrhythmia—Ifosfamide—germ cell cancer	0.00046	0.00298	CcSEcCtD
Furosemide—Aplastic anaemia—Methotrexate—germ cell cancer	0.000456	0.00295	CcSEcCtD
Furosemide—SLCO2A1—lymph node—germ cell cancer	0.000455	0.00377	CbGeAlD
Furosemide—Paraesthesia—Vinblastine—germ cell cancer	0.000455	0.00295	CcSEcCtD
Furosemide—Anaemia—Dactinomycin—germ cell cancer	0.000452	0.00293	CcSEcCtD
Furosemide—CA1—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.000451	0.0105	CbGpPWpGaD
Furosemide—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000449	0.00291	CcSEcCtD
Furosemide—Malnutrition—Ifosfamide—germ cell cancer	0.000448	0.0029	CcSEcCtD
Furosemide—Erythema—Ifosfamide—germ cell cancer	0.000448	0.0029	CcSEcCtD
Furosemide—Renal failure—Etoposide—germ cell cancer	0.000445	0.00288	CcSEcCtD
Furosemide—CA12—brain—germ cell cancer	0.000443	0.00368	CbGeAlD
Furosemide—CA4—adrenal gland—germ cell cancer	0.000443	0.00367	CbGeAlD
Furosemide—Decreased appetite—Vinblastine—germ cell cancer	0.000441	0.00285	CcSEcCtD
Furosemide—Urine output increased—Methotrexate—germ cell cancer	0.000439	0.00284	CcSEcCtD
Furosemide—Bladder pain—Methotrexate—germ cell cancer	0.000439	0.00284	CcSEcCtD
Furosemide—Urinary tract disorder—Cisplatin—germ cell cancer	0.000438	0.00284	CcSEcCtD
Furosemide—Leukopenia—Dactinomycin—germ cell cancer	0.000438	0.00284	CcSEcCtD
Furosemide—CA4—midbrain—germ cell cancer	0.000437	0.00362	CbGeAlD
Furosemide—Urethral disorder—Cisplatin—germ cell cancer	0.000435	0.00282	CcSEcCtD
Furosemide—Pain—Vinblastine—germ cell cancer	0.000434	0.00281	CcSEcCtD
Furosemide—Constipation—Vinblastine—germ cell cancer	0.000434	0.00281	CcSEcCtD
Furosemide—Confusional state—Bleomycin—germ cell cancer	0.000432	0.0028	CcSEcCtD
Furosemide—Hepatobiliary disease—Etoposide—germ cell cancer	0.000429	0.00277	CcSEcCtD
Furosemide—Anaphylactic shock—Bleomycin—germ cell cancer	0.000428	0.00277	CcSEcCtD
Furosemide—CA4—bone marrow—germ cell cancer	0.000428	0.00355	CbGeAlD
Furosemide—Visual impairment—Cisplatin—germ cell cancer	0.000428	0.00277	CcSEcCtD
Furosemide—CA4—spinal cord—germ cell cancer	0.000426	0.00353	CbGeAlD
Furosemide—Agranulocytosis—Etoposide—germ cell cancer	0.000423	0.00274	CcSEcCtD
Furosemide—Vision blurred—Ifosfamide—germ cell cancer	0.000423	0.00274	CcSEcCtD
Furosemide—PGD—brain—germ cell cancer	0.00042	0.00348	CbGeAlD
Furosemide—Thrombocytopenia—Bleomycin—germ cell cancer	0.000419	0.00271	CcSEcCtD
Furosemide—Feeling abnormal—Vinblastine—germ cell cancer	0.000418	0.0027	CcSEcCtD
Furosemide—Eye disorder—Cisplatin—germ cell cancer	0.000415	0.00269	CcSEcCtD
Furosemide—CA1—C-MYB transcription factor network—KITLG—germ cell cancer	0.000415	0.0097	CbGpPWpGaD
Furosemide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000415	0.00268	CcSEcCtD
Furosemide—Anaemia—Ifosfamide—germ cell cancer	0.000414	0.00268	CcSEcCtD
Furosemide—Tinnitus—Cisplatin—germ cell cancer	0.000414	0.00268	CcSEcCtD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000413	0.00966	CbGpPWpGaD
Furosemide—CA4—female gonad—germ cell cancer	0.000413	0.00342	CbGeAlD
Furosemide—Agitation—Ifosfamide—germ cell cancer	0.000412	0.00267	CcSEcCtD
Furosemide—ALB—testis—germ cell cancer	0.000411	0.00341	CbGeAlD
Furosemide—CA2—pituitary gland—germ cell cancer	0.000411	0.00341	CbGeAlD
Furosemide—SLC22A8—head—germ cell cancer	0.000409	0.00339	CbGeAlD
Furosemide—Anorexia—Bleomycin—germ cell cancer	0.000408	0.00264	CcSEcCtD
Furosemide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000407	0.00952	CbGpPWpGaD
Furosemide—Thrombophlebitis—Methotrexate—germ cell cancer	0.000407	0.00263	CcSEcCtD
Furosemide—PGD—lymph node—germ cell cancer	0.000406	0.00336	CbGeAlD
Furosemide—Diabetes mellitus—Methotrexate—germ cell cancer	0.000405	0.00262	CcSEcCtD
Furosemide—SLC22A5—pituitary gland—germ cell cancer	0.000404	0.00335	CbGeAlD
Furosemide—ABCC2—endocrine gland—germ cell cancer	0.000404	0.00335	CbGeAlD
Furosemide—Vertigo—Ifosfamide—germ cell cancer	0.000403	0.00261	CcSEcCtD
Furosemide—Urinary tract disorder—Etoposide—germ cell cancer	0.000402	0.0026	CcSEcCtD
Furosemide—Leukopenia—Ifosfamide—germ cell cancer	0.000401	0.0026	CcSEcCtD
Furosemide—Photosensitivity—Methotrexate—germ cell cancer	0.000401	0.0026	CcSEcCtD
Furosemide—Polyuria—Methotrexate—germ cell cancer	0.000401	0.0026	CcSEcCtD
Furosemide—Immune system disorder—Cisplatin—germ cell cancer	0.000401	0.0026	CcSEcCtD
Furosemide—Abdominal pain—Vinblastine—germ cell cancer	0.000401	0.00259	CcSEcCtD
Furosemide—Hypotension—Bleomycin—germ cell cancer	0.0004	0.00259	CcSEcCtD
Furosemide—Urethral disorder—Etoposide—germ cell cancer	0.000399	0.00258	CcSEcCtD
Furosemide—CA5B—brain—germ cell cancer	0.000398	0.0033	CbGeAlD
Furosemide—Arrhythmia—Cisplatin—germ cell cancer	0.000397	0.00257	CcSEcCtD
Furosemide—CA2—medulla oblongata—germ cell cancer	0.000396	0.00329	CbGeAlD
Furosemide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000391	0.00253	CcSEcCtD
Furosemide—SLC22A5—medulla oblongata—germ cell cancer	0.00039	0.00323	CbGeAlD
Furosemide—Malnutrition—Cisplatin—germ cell cancer	0.000387	0.0025	CcSEcCtD
Furosemide—Erythema—Cisplatin—germ cell cancer	0.000387	0.0025	CcSEcCtD
Furosemide—ABCC2—testis—germ cell cancer	0.000385	0.00319	CbGeAlD
Furosemide—Erythema multiforme—Etoposide—germ cell cancer	0.000385	0.00249	CcSEcCtD
Furosemide—Paraesthesia—Bleomycin—germ cell cancer	0.000384	0.00249	CcSEcCtD
Furosemide—CA5B—lymph node—germ cell cancer	0.000384	0.00319	CbGeAlD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000384	0.00898	CbGpPWpGaD
Furosemide—CA4—endocrine gland—germ cell cancer	0.000384	0.00318	CbGeAlD
Furosemide—Flatulence—Cisplatin—germ cell cancer	0.000381	0.00247	CcSEcCtD
Furosemide—Anorexia—Dactinomycin—germ cell cancer	0.000381	0.00246	CcSEcCtD
Furosemide—Eye disorder—Etoposide—germ cell cancer	0.00038	0.00246	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000379	0.00245	CcSEcCtD
Furosemide—CA4—head—germ cell cancer	0.000379	0.00314	CbGeAlD
Furosemide—Hypersensitivity—Vinblastine—germ cell cancer	0.000373	0.00242	CcSEcCtD
Furosemide—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000373	0.00242	CcSEcCtD
Furosemide—Decreased appetite—Bleomycin—germ cell cancer	0.000372	0.00241	CcSEcCtD
Furosemide—Muscle spasms—Cisplatin—germ cell cancer	0.000372	0.00241	CcSEcCtD
Furosemide—Angiopathy—Etoposide—germ cell cancer	0.000369	0.00239	CcSEcCtD
Furosemide—Confusional state—Ifosfamide—germ cell cancer	0.000369	0.00239	CcSEcCtD
Furosemide—Immune system disorder—Etoposide—germ cell cancer	0.000367	0.00238	CcSEcCtD
Furosemide—CA2—adrenal gland—germ cell cancer	0.000367	0.00304	CbGeAlD
Furosemide—Pain—Bleomycin—germ cell cancer	0.000366	0.00237	CcSEcCtD
Furosemide—CA4—testis—germ cell cancer	0.000366	0.00303	CbGeAlD
Furosemide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000366	0.00237	CcSEcCtD
Furosemide—Vision blurred—Cisplatin—germ cell cancer	0.000364	0.00236	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000364	0.00236	CcSEcCtD
Furosemide—Asthenia—Vinblastine—germ cell cancer	0.000364	0.00235	CcSEcCtD
Furosemide—CA2—midbrain—germ cell cancer	0.000362	0.003	CbGeAlD
Furosemide—SLC22A5—adrenal gland—germ cell cancer	0.000361	0.00299	CbGeAlD
Furosemide—Lethargy—Methotrexate—germ cell cancer	0.000359	0.00233	CcSEcCtD
Furosemide—Nervous system disorder—Ifosfamide—germ cell cancer	0.000359	0.00232	CcSEcCtD
Furosemide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000358	0.00232	CcSEcCtD
Furosemide—Anaemia—Cisplatin—germ cell cancer	0.000357	0.00231	CcSEcCtD
Furosemide—SLC22A5—midbrain—germ cell cancer	0.000356	0.00295	CbGeAlD
Furosemide—Skin disorder—Ifosfamide—germ cell cancer	0.000355	0.0023	CcSEcCtD
Furosemide—CA2—bone marrow—germ cell cancer	0.000355	0.00294	CbGeAlD
Furosemide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000354	0.00229	CcSEcCtD
Furosemide—CA2—spinal cord—germ cell cancer	0.000353	0.00293	CbGeAlD
Furosemide—Feeling abnormal—Bleomycin—germ cell cancer	0.000353	0.00228	CcSEcCtD
Furosemide—CA1—brain—germ cell cancer	0.000351	0.00291	CbGeAlD
Furosemide—Anorexia—Ifosfamide—germ cell cancer	0.000349	0.00226	CcSEcCtD
Furosemide—SLC22A5—spinal cord—germ cell cancer	0.000348	0.00288	CbGeAlD
Furosemide—Decreased appetite—Dactinomycin—germ cell cancer	0.000347	0.00225	CcSEcCtD
Furosemide—Diarrhoea—Vinblastine—germ cell cancer	0.000347	0.00225	CcSEcCtD
Furosemide—Dysgeusia—Etoposide—germ cell cancer	0.000347	0.00225	CcSEcCtD
Furosemide—Leukopenia—Cisplatin—germ cell cancer	0.000346	0.00224	CcSEcCtD
Furosemide—Fatigue—Dactinomycin—germ cell cancer	0.000344	0.00223	CcSEcCtD
Furosemide—CA2—female gonad—germ cell cancer	0.000342	0.00284	CbGeAlD
Furosemide—Hypotension—Ifosfamide—germ cell cancer	0.000342	0.00221	CcSEcCtD
Furosemide—Pain—Dactinomycin—germ cell cancer	0.000341	0.00221	CcSEcCtD
Furosemide—Muscle spasms—Etoposide—germ cell cancer	0.00034	0.0022	CcSEcCtD
Furosemide—Urticaria—Bleomycin—germ cell cancer	0.00034	0.0022	CcSEcCtD
Furosemide—CA1—lymph node—germ cell cancer	0.000339	0.00281	CbGeAlD
Furosemide—Body temperature increased—Bleomycin—germ cell cancer	0.000338	0.00219	CcSEcCtD
Furosemide—CA4—cerebellum—germ cell cancer	0.000338	0.0028	CbGeAlD
Furosemide—SLC22A5—female gonad—germ cell cancer	0.000337	0.00279	CbGeAlD
Furosemide—Irritability—Methotrexate—germ cell cancer	0.000336	0.00218	CcSEcCtD
Furosemide—Dizziness—Vinblastine—germ cell cancer	0.000335	0.00217	CcSEcCtD
Furosemide—Feeling abnormal—Dactinomycin—germ cell cancer	0.000329	0.00213	CcSEcCtD
Furosemide—Paraesthesia—Ifosfamide—germ cell cancer	0.000329	0.00213	CcSEcCtD
Furosemide—Anaemia—Etoposide—germ cell cancer	0.000327	0.00212	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000327	0.00212	CcSEcCtD
Furosemide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000327	0.00211	CcSEcCtD
Furosemide—Somnolence—Ifosfamide—germ cell cancer	0.000325	0.00211	CcSEcCtD
Furosemide—Vomiting—Vinblastine—germ cell cancer	0.000322	0.00209	CcSEcCtD
Furosemide—CA2—endocrine gland—germ cell cancer	0.000318	0.00264	CbGeAlD
Furosemide—Vertigo—Etoposide—germ cell cancer	0.000318	0.00206	CcSEcCtD
Furosemide—Decreased appetite—Ifosfamide—germ cell cancer	0.000318	0.00206	CcSEcCtD
Furosemide—Headache—Vinblastine—germ cell cancer	0.000318	0.00206	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000317	0.00205	CcSEcCtD
Furosemide—Leukopenia—Etoposide—germ cell cancer	0.000317	0.00205	CcSEcCtD
Furosemide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000316	0.00205	CcSEcCtD
Furosemide—Abdominal pain—Dactinomycin—germ cell cancer	0.000316	0.00204	CcSEcCtD
Furosemide—Body temperature increased—Dactinomycin—germ cell cancer	0.000316	0.00204	CcSEcCtD
Furosemide—Fatigue—Ifosfamide—germ cell cancer	0.000315	0.00204	CcSEcCtD
Furosemide—Anaphylactic shock—Cisplatin—germ cell cancer	0.000315	0.00204	CcSEcCtD
Furosemide—Hypersensitivity—Bleomycin—germ cell cancer	0.000315	0.00204	CcSEcCtD
Furosemide—CA2—head—germ cell cancer	0.000314	0.0026	CbGeAlD
Furosemide—Constipation—Ifosfamide—germ cell cancer	0.000313	0.00203	CcSEcCtD
Furosemide—Pain—Ifosfamide—germ cell cancer	0.000313	0.00203	CcSEcCtD
Furosemide—Nervous system disorder—Cisplatin—germ cell cancer	0.000309	0.002	CcSEcCtD
Furosemide—Thrombocytopenia—Cisplatin—germ cell cancer	0.000309	0.002	CcSEcCtD
Furosemide—ALB—brain—germ cell cancer	0.000309	0.00256	CbGeAlD
Furosemide—Asthenia—Bleomycin—germ cell cancer	0.000307	0.00199	CcSEcCtD
Furosemide—Skin disorder—Cisplatin—germ cell cancer	0.000306	0.00198	CcSEcCtD
Furosemide—Hyperhidrosis—Cisplatin—germ cell cancer	0.000305	0.00197	CcSEcCtD
Furosemide—CA2—testis—germ cell cancer	0.000303	0.00252	CbGeAlD
Furosemide—Pruritus—Bleomycin—germ cell cancer	0.000303	0.00196	CcSEcCtD
Furosemide—Feeling abnormal—Ifosfamide—germ cell cancer	0.000302	0.00195	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—germ cell cancer	0.000301	0.00195	CcSEcCtD
Furosemide—Nausea—Vinblastine—germ cell cancer	0.000301	0.00195	CcSEcCtD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000301	0.00704	CbGpPWpGaD
Furosemide—Anorexia—Cisplatin—germ cell cancer	0.000301	0.00195	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000299	0.00194	CcSEcCtD
Furosemide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000299	0.00194	CcSEcCtD
Furosemide—SLC22A5—testis—germ cell cancer	0.000299	0.00247	CbGeAlD
Furosemide—Pancreatitis—Methotrexate—germ cell cancer	0.000298	0.00193	CcSEcCtD
Furosemide—ALB—lymph node—germ cell cancer	0.000298	0.00247	CbGeAlD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000296	0.00693	CbGpPWpGaD
Furosemide—SLC22A8—brain—germ cell cancer	0.000296	0.00246	CbGeAlD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000295	0.0069	CbGpPWpGaD
Furosemide—Hypotension—Cisplatin—germ cell cancer	0.000295	0.00191	CcSEcCtD
Furosemide—Hypersensitivity—Dactinomycin—germ cell cancer	0.000294	0.0019	CcSEcCtD
Furosemide—Confusional state—Etoposide—germ cell cancer	0.000291	0.00189	CcSEcCtD
Furosemide—Urticaria—Ifosfamide—germ cell cancer	0.000291	0.00188	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000291	0.00679	CbGpPWpGaD
Furosemide—Body temperature increased—Ifosfamide—germ cell cancer	0.000289	0.00187	CcSEcCtD
Furosemide—Abdominal pain—Ifosfamide—germ cell cancer	0.000289	0.00187	CcSEcCtD
Furosemide—Anaphylactic shock—Etoposide—germ cell cancer	0.000289	0.00187	CcSEcCtD
Furosemide—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	0.000289	0.00675	CbGpPWpGaD
Furosemide—Asthenia—Dactinomycin—germ cell cancer	0.000286	0.00185	CcSEcCtD
Furosemide—Paraesthesia—Cisplatin—germ cell cancer	0.000283	0.00183	CcSEcCtD
Furosemide—CA1—C-MYB transcription factor network—KIT—germ cell cancer	0.000283	0.00662	CbGpPWpGaD
Furosemide—Thrombocytopenia—Etoposide—germ cell cancer	0.000283	0.00183	CcSEcCtD
Furosemide—Skin disorder—Etoposide—germ cell cancer	0.000281	0.00182	CcSEcCtD
Furosemide—CA2—cerebellum—germ cell cancer	0.00028	0.00232	CbGeAlD
Furosemide—Hyperhidrosis—Etoposide—germ cell cancer	0.000279	0.00181	CcSEcCtD
Furosemide—ABCC2—lymph node—germ cell cancer	0.000279	0.00232	CbGeAlD
Furosemide—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000278	0.0018	CcSEcCtD
Furosemide—SLC22A5—cerebellum—germ cell cancer	0.000276	0.00229	CbGeAlD
Furosemide—Anorexia—Etoposide—germ cell cancer	0.000275	0.00178	CcSEcCtD
Furosemide—CA4—brain—germ cell cancer	0.000275	0.00228	CbGeAlD
Furosemide—Decreased appetite—Cisplatin—germ cell cancer	0.000274	0.00178	CcSEcCtD
Furosemide—Diarrhoea—Dactinomycin—germ cell cancer	0.000273	0.00177	CcSEcCtD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000273	0.00639	CbGpPWpGaD
Furosemide—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000272	0.00176	CcSEcCtD
Furosemide—Vomiting—Bleomycin—germ cell cancer	0.000272	0.00176	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—germ cell cancer	0.000271	0.00176	CcSEcCtD
Furosemide—Hypotension—Etoposide—germ cell cancer	0.00027	0.00175	CcSEcCtD
Furosemide—Rash—Bleomycin—germ cell cancer	0.00027	0.00175	CcSEcCtD
Furosemide—Pain—Cisplatin—germ cell cancer	0.00027	0.00175	CcSEcCtD
Furosemide—Dermatitis—Bleomycin—germ cell cancer	0.00027	0.00175	CcSEcCtD
Furosemide—Hypersensitivity—Ifosfamide—germ cell cancer	0.00027	0.00175	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000269	0.00174	CcSEcCtD
Furosemide—Renal failure—Methotrexate—germ cell cancer	0.000267	0.00173	CcSEcCtD
Furosemide—CA4—lymph node—germ cell cancer	0.000265	0.0022	CbGeAlD
Furosemide—Asthenia—Ifosfamide—germ cell cancer	0.000263	0.0017	CcSEcCtD
Furosemide—Sweating—Methotrexate—germ cell cancer	0.00026	0.00168	CcSEcCtD
Furosemide—Feeling abnormal—Cisplatin—germ cell cancer	0.00026	0.00168	CcSEcCtD
Furosemide—Paraesthesia—Etoposide—germ cell cancer	0.00026	0.00168	CcSEcCtD
Furosemide—Pruritus—Ifosfamide—germ cell cancer	0.000259	0.00168	CcSEcCtD
Furosemide—Somnolence—Etoposide—germ cell cancer	0.000257	0.00166	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000257	0.00166	CcSEcCtD
Furosemide—Nausea—Bleomycin—germ cell cancer	0.000254	0.00165	CcSEcCtD
Furosemide—Vomiting—Dactinomycin—germ cell cancer	0.000254	0.00164	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—germ cell cancer	0.000253	0.00164	CcSEcCtD
Furosemide—Rash—Dactinomycin—germ cell cancer	0.000252	0.00163	CcSEcCtD
Furosemide—Decreased appetite—Etoposide—germ cell cancer	0.000251	0.00163	CcSEcCtD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000251	0.00587	CbGpPWpGaD
Furosemide—Diarrhoea—Ifosfamide—germ cell cancer	0.00025	0.00162	CcSEcCtD
Furosemide—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00025	0.00162	CcSEcCtD
Furosemide—Body temperature increased—Cisplatin—germ cell cancer	0.000249	0.00161	CcSEcCtD
Furosemide—Fatigue—Etoposide—germ cell cancer	0.000249	0.00161	CcSEcCtD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000249	0.00582	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000247	0.00579	CbGpPWpGaD
Furosemide—Pain—Etoposide—germ cell cancer	0.000247	0.0016	CcSEcCtD
Furosemide—Constipation—Etoposide—germ cell cancer	0.000247	0.0016	CcSEcCtD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000245	0.00573	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—CD9—germ cell cancer	0.000243	0.00569	CbGpPWpGaD
Furosemide—Dizziness—Ifosfamide—germ cell cancer	0.000242	0.00157	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—germ cell cancer	0.000241	0.00156	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—germ cell cancer	0.000239	0.00155	CcSEcCtD
Furosemide—Feeling abnormal—Etoposide—germ cell cancer	0.000238	0.00154	CcSEcCtD
Furosemide—Nausea—Dactinomycin—germ cell cancer	0.000237	0.00154	CcSEcCtD
Furosemide—Gastrointestinal pain—Etoposide—germ cell cancer	0.000236	0.00153	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—germ cell cancer	0.000235	0.00152	CcSEcCtD
Furosemide—Vomiting—Ifosfamide—germ cell cancer	0.000233	0.00151	CcSEcCtD
Furosemide—Hypersensitivity—Cisplatin—germ cell cancer	0.000232	0.0015	CcSEcCtD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000232	0.00542	CbGpPWpGaD
Furosemide—Rash—Ifosfamide—germ cell cancer	0.000231	0.00149	CcSEcCtD
Furosemide—Dermatitis—Ifosfamide—germ cell cancer	0.000231	0.00149	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—germ cell cancer	0.00023	0.00149	CcSEcCtD
Furosemide—Urticaria—Etoposide—germ cell cancer	0.00023	0.00149	CcSEcCtD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000229	0.00536	CbGpPWpGaD
Furosemide—Abdominal pain—Etoposide—germ cell cancer	0.000228	0.00148	CcSEcCtD
Furosemide—Body temperature increased—Etoposide—germ cell cancer	0.000228	0.00148	CcSEcCtD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000228	0.00533	CbGpPWpGaD
Furosemide—Eye disorder—Methotrexate—germ cell cancer	0.000228	0.00147	CcSEcCtD
Furosemide—CA2—brain—germ cell cancer	0.000228	0.00189	CbGeAlD
Furosemide—Tinnitus—Methotrexate—germ cell cancer	0.000227	0.00147	CcSEcCtD
Furosemide—Asthenia—Cisplatin—germ cell cancer	0.000226	0.00147	CcSEcCtD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000225	0.00526	CbGpPWpGaD
Furosemide—SLC22A5—brain—germ cell cancer	0.000224	0.00186	CbGeAlD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000222	0.00518	CbGpPWpGaD
Furosemide—Angiopathy—Methotrexate—germ cell cancer	0.000221	0.00143	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—germ cell cancer	0.00022	0.00142	CcSEcCtD
Furosemide—CA2—lymph node—germ cell cancer	0.00022	0.00182	CbGeAlD
Furosemide—Nausea—Ifosfamide—germ cell cancer	0.000217	0.00141	CcSEcCtD
Furosemide—SLC22A5—lymph node—germ cell cancer	0.000216	0.00179	CbGeAlD
Furosemide—Diarrhoea—Cisplatin—germ cell cancer	0.000216	0.0014	CcSEcCtD
Furosemide—Hypersensitivity—Etoposide—germ cell cancer	0.000213	0.00138	CcSEcCtD
Furosemide—Erythema—Methotrexate—germ cell cancer	0.000212	0.00137	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—germ cell cancer	0.000212	0.00137	CcSEcCtD
Furosemide—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00021	0.0049	CbGpPWpGaD
Furosemide—Dysgeusia—Methotrexate—germ cell cancer	0.000208	0.00134	CcSEcCtD
Furosemide—Asthenia—Etoposide—germ cell cancer	0.000207	0.00134	CcSEcCtD
Furosemide—Pruritus—Etoposide—germ cell cancer	0.000204	0.00132	CcSEcCtD
Furosemide—Vomiting—Cisplatin—germ cell cancer	0.000201	0.0013	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—germ cell cancer	0.0002	0.00129	CcSEcCtD
Furosemide—Rash—Cisplatin—germ cell cancer	0.000199	0.00129	CcSEcCtD
Furosemide—Dermatitis—Cisplatin—germ cell cancer	0.000199	0.00129	CcSEcCtD
Furosemide—Diarrhoea—Etoposide—germ cell cancer	0.000198	0.00128	CcSEcCtD
Furosemide—Anaemia—Methotrexate—germ cell cancer	0.000196	0.00127	CcSEcCtD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000193	0.00452	CbGpPWpGaD
Furosemide—Dizziness—Etoposide—germ cell cancer	0.000191	0.00124	CcSEcCtD
Furosemide—Vertigo—Methotrexate—germ cell cancer	0.000191	0.00123	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—germ cell cancer	0.00019	0.00123	CcSEcCtD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000188	0.00439	CbGpPWpGaD
Furosemide—Nausea—Cisplatin—germ cell cancer	0.000187	0.00121	CcSEcCtD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000185	0.00432	CbGpPWpGaD
Furosemide—Vomiting—Etoposide—germ cell cancer	0.000184	0.00119	CcSEcCtD
Furosemide—Rash—Etoposide—germ cell cancer	0.000182	0.00118	CcSEcCtD
Furosemide—Dermatitis—Etoposide—germ cell cancer	0.000182	0.00118	CcSEcCtD
Furosemide—Headache—Etoposide—germ cell cancer	0.000181	0.00117	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000179	0.00116	CcSEcCtD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000175	0.00409	CbGpPWpGaD
Furosemide—Confusional state—Methotrexate—germ cell cancer	0.000175	0.00113	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—germ cell cancer	0.000173	0.00112	CcSEcCtD
Furosemide—Nausea—Etoposide—germ cell cancer	0.000172	0.00111	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—germ cell cancer	0.00017	0.0011	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—germ cell cancer	0.000169	0.0011	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—germ cell cancer	0.000168	0.00109	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—germ cell cancer	0.000167	0.00108	CcSEcCtD
Furosemide—Anorexia—Methotrexate—germ cell cancer	0.000165	0.00107	CcSEcCtD
Furosemide—Hypotension—Methotrexate—germ cell cancer	0.000162	0.00105	CcSEcCtD
Furosemide—CA9—Cellular responses to stress—H2AFZ—germ cell cancer	0.000159	0.00371	CbGpPWpGaD
Furosemide—CA1—C-MYB transcription factor network—MYC—germ cell cancer	0.000156	0.00364	CbGpPWpGaD
Furosemide—Paraesthesia—Methotrexate—germ cell cancer	0.000155	0.00101	CcSEcCtD
Furosemide—PGD—Disease—SLC2A3—germ cell cancer	0.000154	0.0036	CbGpPWpGaD
Furosemide—Somnolence—Methotrexate—germ cell cancer	0.000154	0.000996	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—germ cell cancer	0.00015	0.000974	CcSEcCtD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00015	0.00351	CbGpPWpGaD
Furosemide—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000149	0.000968	CcSEcCtD
Furosemide—Fatigue—Methotrexate—germ cell cancer	0.000149	0.000966	CcSEcCtD
Furosemide—Pain—Methotrexate—germ cell cancer	0.000148	0.000958	CcSEcCtD
Furosemide—SLC22A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000148	0.00345	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000146	0.00341	CbGpPWpGaD
Furosemide—Feeling abnormal—Methotrexate—germ cell cancer	0.000143	0.000924	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000142	0.000917	CcSEcCtD
Furosemide—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000141	0.0033	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000139	0.00325	CbGpPWpGaD
Furosemide—Urticaria—Methotrexate—germ cell cancer	0.000138	0.00089	CcSEcCtD
Furosemide—CA14—Metabolism—SLC2A3—germ cell cancer	0.000137	0.00321	CbGpPWpGaD
Furosemide—Body temperature increased—Methotrexate—germ cell cancer	0.000137	0.000886	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—germ cell cancer	0.000137	0.000886	CcSEcCtD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000136	0.00318	CbGpPWpGaD
Furosemide—CA14—Metabolism—SLC22A3—germ cell cancer	0.000135	0.00316	CbGpPWpGaD
Furosemide—CA6—Metabolism—SLC2A3—germ cell cancer	0.000134	0.00313	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SLC2A3—germ cell cancer	0.000134	0.00313	CbGpPWpGaD
Furosemide—CA5A—Metabolism—SLC22A3—germ cell cancer	0.000132	0.00308	CbGpPWpGaD
Furosemide—CA6—Metabolism—SLC22A3—germ cell cancer	0.000132	0.00308	CbGpPWpGaD
Furosemide—PGD—Metabolism—SLC2A3—germ cell cancer	0.000129	0.00302	CbGpPWpGaD
Furosemide—Hypersensitivity—Methotrexate—germ cell cancer	0.000128	0.000826	CcSEcCtD
Furosemide—PGD—Metabolism—SLC22A3—germ cell cancer	0.000127	0.00297	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000126	0.00296	CbGpPWpGaD
Furosemide—CA7—Metabolism—SLC2A3—germ cell cancer	0.000125	0.00292	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC2A3—germ cell cancer	0.000125	0.00292	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000125	0.00291	CbGpPWpGaD
Furosemide—Asthenia—Methotrexate—germ cell cancer	0.000124	0.000804	CcSEcCtD
Furosemide—CA7—Metabolism—SLC22A3—germ cell cancer	0.000123	0.00287	CbGpPWpGaD
Furosemide—CA5B—Metabolism—SLC22A3—germ cell cancer	0.000123	0.00287	CbGpPWpGaD
Furosemide—Pruritus—Methotrexate—germ cell cancer	0.000122	0.000793	CcSEcCtD
Furosemide—CA1—C-MYB transcription factor network—HRAS—germ cell cancer	0.000122	0.00286	CbGpPWpGaD
Furosemide—Diarrhoea—Methotrexate—germ cell cancer	0.000118	0.000767	CcSEcCtD
Furosemide—SLC12A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000116	0.00271	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC2A3—germ cell cancer	0.000116	0.0027	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000115	0.00268	CbGpPWpGaD
Furosemide—Dizziness—Methotrexate—germ cell cancer	0.000114	0.000741	CcSEcCtD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000114	0.00267	CbGpPWpGaD
Furosemide—CA12—Metabolism—SLC22A3—germ cell cancer	0.000114	0.00266	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000113	0.00263	CbGpPWpGaD
Furosemide—CA14—Metabolism—CRABP1—germ cell cancer	0.00011	0.00258	CbGpPWpGaD
Furosemide—Vomiting—Methotrexate—germ cell cancer	0.00011	0.000713	CcSEcCtD
Furosemide—Rash—Methotrexate—germ cell cancer	0.000109	0.000707	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—germ cell cancer	0.000109	0.000706	CcSEcCtD
Furosemide—Headache—Methotrexate—germ cell cancer	0.000108	0.000702	CcSEcCtD
Furosemide—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000108	0.00252	CbGpPWpGaD
Furosemide—CA6—Metabolism—CRABP1—germ cell cancer	0.000107	0.00251	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CRABP1—germ cell cancer	0.000107	0.00251	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000104	0.00243	CbGpPWpGaD
Furosemide—PGD—Metabolism—CRABP1—germ cell cancer	0.000104	0.00242	CbGpPWpGaD
Furosemide—Nausea—Methotrexate—germ cell cancer	0.000103	0.000666	CcSEcCtD
Furosemide—CA5B—Metabolism—CRABP1—germ cell cancer	0.0001	0.00234	CbGpPWpGaD
Furosemide—CA7—Metabolism—CRABP1—germ cell cancer	0.0001	0.00234	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.76e-05	0.00228	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.61e-05	0.00225	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.54e-05	0.00223	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.4e-05	0.0022	CbGpPWpGaD
Furosemide—CA12—Metabolism—CRABP1—germ cell cancer	9.28e-05	0.00217	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.24e-05	0.00216	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC2A3—germ cell cancer	9.22e-05	0.00216	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.1e-05	0.00213	CbGpPWpGaD
Furosemide—CA4—Metabolism—SLC22A3—germ cell cancer	9.08e-05	0.00212	CbGpPWpGaD
Furosemide—PGD—Disease—FGF4—germ cell cancer	8.84e-05	0.00207	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC2A3—germ cell cancer	8.84e-05	0.00207	CbGpPWpGaD
Furosemide—CA2—Metabolism—SLC22A3—germ cell cancer	8.7e-05	0.00204	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	8.66e-05	0.00202	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC2A3—germ cell cancer	8.47e-05	0.00198	CbGpPWpGaD
Furosemide—CA1—Metabolism—SLC22A3—germ cell cancer	8.35e-05	0.00195	CbGpPWpGaD
Furosemide—PGD—Disease—H2AFZ—germ cell cancer	7.9e-05	0.00185	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.58e-05	0.00177	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC2A3—germ cell cancer	7.45e-05	0.00174	CbGpPWpGaD
Furosemide—CA4—Metabolism—CRABP1—germ cell cancer	7.4e-05	0.00173	CbGpPWpGaD
Furosemide—CA9—Metabolism—SLC22A3—germ cell cancer	7.34e-05	0.00172	CbGpPWpGaD
Furosemide—PGD—Disease—KITLG—germ cell cancer	7.26e-05	0.0017	CbGpPWpGaD
Furosemide—CA2—Metabolism—CRABP1—germ cell cancer	7.1e-05	0.00166	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—AVP—germ cell cancer	6.91e-05	0.00162	CbGpPWpGaD
Furosemide—CA1—Metabolism—CRABP1—germ cell cancer	6.8e-05	0.00159	CbGpPWpGaD
Furosemide—CA9—Metabolism—CRABP1—germ cell cancer	5.98e-05	0.0014	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	5.83e-05	0.00136	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD9—germ cell cancer	5.56e-05	0.0013	CbGpPWpGaD
Furosemide—PGD—Disease—FGFR3—germ cell cancer	5.4e-05	0.00126	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	5.27e-05	0.00123	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.96e-05	0.00116	CbGpPWpGaD
Furosemide—PGD—Disease—KIT—germ cell cancer	4.96e-05	0.00116	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.89e-05	0.00114	CbGpPWpGaD
Furosemide—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.5e-05	0.00105	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—germ cell cancer	4.5e-05	0.00105	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	4.4e-05	0.00103	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.26e-05	0.000997	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—germ cell cancer	4.25e-05	0.000994	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.19e-05	0.000979	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—germ cell cancer	2.73e-05	0.000638	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A3—germ cell cancer	2.32e-05	0.000543	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC22A3—germ cell cancer	2.29e-05	0.000535	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	2.29e-05	0.000535	CbGpPWpGaD
Furosemide—PGD—Disease—HRAS—germ cell cancer	2.14e-05	0.000501	CbGpPWpGaD
Furosemide—ALB—Metabolism—CRABP1—germ cell cancer	1.87e-05	0.000436	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—germ cell cancer	8.34e-06	0.000195	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HRAS—germ cell cancer	7.97e-06	0.000186	CbGpPWpGaD
